Antithrombotics after infra-inguinal peripheral endovascular treatment

Abstract

To determine the e ects of antithrombotic agents compared with each other, with placebo, or with no treatment, in people with infrainguinal (below the anatomical level of the inguinal ligament) peripheral arterial disease who are undergoing peripheral endovascular treatment. Antithrombotics a er infra-inguinal peripheral endovascular treatment (Protocol)